Company Files

Subscribe Receive Corporate Watch News via e-mail:

About Us About Corporate Watch Support our work Contacts & Links

Corporate Watch
c/o Freedom Press
Angel Alley
84b Whitechapel High Street
London, E1 7QX
t: +44 (0)207 426 0005
e: contact[at]corporatewatch.org
 
Who, Where, How Much?

GlaxoSmithKline plc

A Corporate Profile

By Corporate Watch UK
Completed November 2002

2. Who, where, how much?


Head office

Headquarters in the UK, with Operations based in the U.S.

United Kingdom:
GlaxoSmithKline,
Glaxo Wellcome UK Ltd.,
Stockley Park West,
Uxbridge,
Middlesex, UB11 1BT
General Enquiries:
Tel: +44 (0)20 8990 9000
Fax: +44 (0)20 8990 4321

United States:
GlaxoSmithKline
5 Moore Drive
P.O. Box 13398
Research Triangle Park
NC 27709
Phone: +1 888 825 5249
Company Structure/Ownership
GlaxoSmithKline plc is a publicly owned company.

Board of Directors [11]

Sir Christopher Hogg, Chairman
Sir Hogg was appointed to the Board of SmithKline Beecham as a Non-executive Director in 1993. He is Non-executive Chairman of Reuters Group PLC and Allied Domecq PLC, and a Non-executive Director of Air Liquide S.A.

J.P. Garnier, Chief Executive Officer
Mr. Garnier became CEO of GSK in 2000. In August 2001 he was listed in the Guardian among the top ten highest paid CEOs, earning £2.5 million per year (including options and bonuses). [12] He also contributes to the ‘quality of human life’ by sitting on the board of arms manufacturer United Technologies, the maker of the Blackhawk helicopter and other warplanes. [13]

John Coome, Chief Financial Officer
Mr Coombe joined Glaxo Holdings as Group Financial Controller in 1986 and was appointed to the Board in July 1992. His other business appointments include membership of the Accounting Standards Board, Deputy Chairman of The Hundred Group of Finance Directors and a member of the Code Committee of the Takeover Panel.

Paul Allaire, Chairman of Remuneration and Nominations Committee
Born on 21st July 1938, Paul Allaire was appointed to the Board of SmithKline Beecham as a Non-Executive Director in 1993. He is also Chairman of Xerox Corporation and a Non-executive Director of JP Morgan & Co. Inc, Lucent Technologies Inc, Sara Lee Corporation and Priceline.com Inc. Food giant Sara Lee is regularly criticised for selling unhealthy food. While Glaxo’s ‘mission statement’ includes ‘enabling people to do more, feel better and live longer’ Sara Lee pleaded guilty in June 2001 to selling bad meat that killed 15 people and caused six miscarriages. He is also on the Board of Trustee of Carnegie Mellon University.[14]

Dr. Michele Barzach, Non-Executive Director
Appointed as a Non-executive Director of Glaxo Wellcome in 1997. Dr. Barzach also works for the World Bank as Chairman of the External Advisory Panel for Health, Nutrition and Population. She was formerly French Minister of Health and the Family.[15]

Sir Roger Hurm, Non-Executive Deputy Chairman
Born 9th June 1938, Sir Roger was appointed non-executive Director of Glaxo Wellcome plc in 1996 and Deputy Chairman in 1997. He was also Chairman of Marconi (formerly GEC) until he was forced to resign in September 2001 due to the companies collapsing share prices. He is a Non-executive Director of ICI plc. ICI was number one in the Environment Agency’s 1999 ‘hall of shame’ league table of polluters.[16]

Sir Peter Job, Non-Executive Director
Sir Peter Job is a Non-executive Director of GlaxoSmithKline. He was appointed as a Non-executive Director of Glaxo Wellcome in 1997 and is a Non-executive Director of Schroders plc. Sir Peter was awarded a Knight of the British Empire (KBE) by the queen. The honour was received for services to the information and media industry.[17]

John McArthur, Non-Executive Director
He was appointed as a Non-executive Director of Glaxo Wellcome in 1996. He is a former Dean of the Harvard Business School, and is a Director of BCE Inc., Cabot Corporation, Rohm and Haas Company, Springs Industries Inc. and The AES Corporation.[18]

Donald McHenry, Non-Executive Director
Born on 13th October 1936, Donald McHenry was appointed to the Board of SmithKline Beecham as a Non-executive Director in 1989. He is a Non-executive director of the Coca-Cola Company, which has been criticised for its labour and environmental practices and the aggressive marketing of its high-sugar drinks. Other Non-executive Directorships include FleetBoston Financial Corporation and AT&T Corporation . He previously served as Ambassador and US Permanent Representative to the United Nations. [19]

Sir Ian Prosser, Non-Executive Director
Born 5th July 1943, Ian Prosser was appointed to the Board of SmithKline Beecham as a Non-executive Director in 1999. He is Executive Chairman of the pub owner Bass PLC. In addition he non-executive Deputy Chairman of BP Amoco plc, a company criticised for its pollution record He is also a member of the CBI President's Committee, an industry lobby group.[20]

Dr. Ronaldo Schmitz, Chairman of Audit Committee
Mr. Schmitz was appointed as a Non-executive Director of Glaxo Wellcome in 1997. He is also a former member of the Board of Managing Directors of Deutsche Bank AG and a member of the Supervisory Board of Bertelsmann AG and the Board of Directors of Rohm and Haas Company.[21]

Dr. Lucy Shapiro, Non-Executive Director
Dr. Shapiro was appointed to the Board of SmithKline Beecham as a Non-executive Director in 1996. She is Professor in the Department of Developmental Biology and Director of the Beckman Center at the Stanford University School of Medicine.[22]

Turnover
In 2001, GlaxoSmithKline had sales totalling £20.5 billion, and before tax profits of £6.2 billion.[23]

Number of Employees
GSK employs 100,000 people, 40,000 of which work in Sales and Marketing.[24]

References
[11] <www.gsk.com/about/boardofdirectors.htm> (source: GlaxoSmithKline, date viewed: 02.11.02)
[12] <www.guardian.co.uk/business/story/0,3604,543692,00.html> Top 10: The chief executives, Wednesday August 29, 2001
[13] <www.gsk.com/about/boardofdirectors.htm> (source: GlaxoSmithKline, date viewed: 02.11.02)
[14] GSK Profile, www.marketguide.com <www.marketguide.com/>; Hugues S, (2001) In Health and Sickness, The Ecologist, 31(8): 53-54; Who’s Who 2001, A & C Black, p. 25.
[15] GSK Profile, www.marketguide.com <www.marketguide.com/>
[16] GSK Profile, www.marketguide.com <www.marketguide.com/>; City welcomes Marconi departures but reserves judgement on new regime, Julia Finch, City editor, Wednesday September 5, 2001, <www.guardian.co.uk/business/story/0,3604,546999,00.html>; City welcomes Marconi departures but reserves judgement on new regime, Julia Finch, City editor, Wednesday September 5, 2001, <www.guardian.co.uk/business/story/0,3604,546999,00.html>; Hugues S, (2001) In Health and Sickness, The Ecologist, 31(8):53-54; Who’s Who 2001, A & C Black, p. 1044.
[18] <www.gsk.com/about/boardofdirectors.htm> (source: GlaxoSmithKline, date viewed: 02.11.02)
[19] GSK Profile, www.marketguide.com <www.marketguide.com/>; Ethical Consumer 65, June/July 2000 - Research Supplement, pp. 12-13; Who’s Who 2001, A & C Black.
[20] GSK Profile, www.marketguide.com <www.marketguide.com/>; Hugues S, (2001) In Health and Sickness, The Ecologist, 31(8): 53-54; Who’s Who 2001, A & C Black, p.1687.
[21] <www.gsk.com/about/boardofdirectors.htm> (source: GlaxoSmithKline, date viewed: 02.11.02)
[22] <www.gsk.com/about/boardofdirectors.htm> (source: GlaxoSmithKline, date viewed: 02.11.02)
[23] GlaxoSmithKline Annual Report 2001
[24] www.gsk.com/about/about.htm (source: GlaxoSmithKline, date viewed: 28/10/2002)

 
powered by the Webbler | tincan